1,420.00

Content Details
Information on this page was last modified on : 2021/04/28 3:48:23 PM

Terlip Injection 1 mg 1 Vial

Terlip Injection contains Terlipressin | belongs to Vasopressin analogue

Alternate brands of Terlip Injection 1 mg 1 Vial

Brand Name Price Savings
Novapressin Injection 1 mg 1 Vial  1,400.00 You can save 20
List of alternate brands

How it works

Terlip Injection 1 mg 1 Vial acts on receptors in the kidney to retain water in the body, which helps to prevent excessive loss of water in the urine.

Side effects

Major & minor side effects for Terlip Injection 1 mg 1 Vial

  • Headache
  • Abdominal cramps
  • Nausea
  • Diarrhea
  • Pale skin
  • Chest pain
  • Shortness of breath
  • Vomiting
  • Irregular heartbeat
  • Increased blood sugar levels rare

Uses of Terlip Injection 1 mg 1 Vial

What is it prescribed for?

  • Bleeding Esophageal Varices

    This medicine is used to treat the bleeding of dilated blood vessels of the esophagus which develops when the blood flow to the liver is reduced due to a blood clot within the liver or scar tissue.

  • Type 1 Hepatorenal Syndrome

    This medicine is used in the treatment of type 1 hepatorenal syndrome (progressive kidney failure in people with severe liver damage) characterized by rapid kidney failure and an increase in the levels of creatinine.

Concerns

Frequently asked questions

  • Onset of action

    The amount of time required for this medicine to show its action is not clinically established.

  • Duration of Effect

    The amount of time for which this medicine remains active in the body is not clinically established.

  • Safe with Alchohol?

    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

  • Is it habit forming?

    No habit-forming tendencies were reported.

  • Usage in pregnancy?

    This medicine is not recommended for use in pregnant women unless absolutely necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

  • Usage while breast-feeding?

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

When not to use?

  • Allergy

    This medicine is not recommended for use in patients with a known allergy to Terlip Injection 1 mg 1 Vial or any other inactive ingredients present along with it.

Warnings

Warnings for special population
  • Pregnancy

    This medicine is not recommended for use in pregnant women unless absolutely necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

  • Breast-feeding

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

General Warnings
  • Septic shock

    This medicine should be used with extreme caution in patients with septic shock due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

  • Chronic kidney impairment

    This medicine should be used with extreme caution in patients with an impaired kidney function due to the increased risk of severe adverse effects. Close monitoring of kidney function, appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.

  • Heart disorders

    This medicine should be used with caution in patients with heart disorders such as arrhythmias, acute coronary syndrome, or recent myocardial infarction, etc due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

  • Cerebral or peripheral vascular disorders

    This medicine should be used with caution in patients with cerebral or peripheral vascular disorders due to the increased risk of worsening of the patient's condition. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

  • Use in elderly

    This medicine should be used with caution in patients aged above 70 years due to the increased risk of adverse effects. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

  • Use in children

    This medicine is not recommended for use in children below 18 years of age since the safety and efficacy of use are not clinically established.

Dosage

  • Missed Dose

    Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of a missed dose is very less.

  • Overdose

    Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.

Interactions

Interaction with Medicines
  • Aliskiren
  • antihistamines
  • Propofol
  • Erythromycin
  • Tricyclic Antidepressants
  • Class IA & III Antiarrythmic agents

General Instructions

This medicine should be administered by a qualified healthcare professional. Inform the doctor if you have a known history of allergy to this medicine. Report to the doctor all your current medicines as well as your medical conditions before receiving this medicine.

Other details

  • Usage does not depend on food timings
  • To be taken as instructed by doctor
  • Does not cause sleepiness

References

Additional Information:

How to use Terlip Injection 1 mg 1 Vial

Administered by IV bolus injection.
Stability: Frozen dried powder and the diluent may be stored at room temperature, protected from direct sunlight. Reconstituted solution should be used within 12 hours.

UNLICENSED USE
Children: Adjunct in acute massive haemorrhage of GI tract or oesophageal varices: IV. 12-18 yr, 2 mg every 4 hr until bleeding controlled (after initial dose, may reduce to 1 mg every 4 hr if not tolerated or body-weight under 50 kg), max duration 48 hr.

what are the adverse effects of Terlip Injection 1 mg 1 Vial?

Abdominal cramps, headache, transient blanching, hypertension.

What happens if I miss a dose of Terlip Injection 1 mg 1 Vial?

Adults: 2 mg IV bolus injection, followed by 1 mg or 2 mg every 4 to 6 hr up to max 72 hr. Children: Not recommended.

One of the following licensed pharmacy from the nearest location will deliver Terlip Injection 1 mg 1 Vial. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Want to share this information?
Facebook
Twitter
LinkedIn
Something doesn't feel right ?

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions

Reviews

There are no reviews yet.

Be the first to review “Terlip Injection 1 mg 1 Vial”
Shopping Cart